Skip to main content
. 2022 Sep 29;26(12):2385–2395. doi: 10.1007/s10995-022-03557-5

Table 2.

Bivariate analysis of maternal demographics and receipt of antepartum Tdap vaccine

Characteristic Vaccinated N = 736 n (%) Not vaccinated N = 835 n (%) Unadjusted ORa for not vaccinated (95% CI) p-value*
Race/Ethnicity 0.0003
 White non-Hispanic 266 (48.9%) 278 (51.1%)
 Black non-Hispanic 118 (43.1%) 156 (56.9%) 1.26 (0.94–1.69)
 Asian non-Hispanic 152 (57.4%) 113 (42.6%) 0.71 (0.53–0.96)
 Hispanic 112 (39.7%) 170 (60.3%) 1.45 (1.08–1.94)
 All other non-Hispanic 55 (42.0%) 76 (58.0%) 1.32 (0.90–1.94)
Age group (years) 0.0077
 18–24 58 (36.5%) 101 (63.5%)
 25–34 441 (49.8%) 445 (50.2%) 0.58 (0.41–0.82)
  ≥ 35 202 (46.2%) 235 (53.8%) 0.67 (0.46–0.97)
Received prenatal care during first trimester 0.14
 Yes 681 (47.6%) 749 (52.4%) 0.73 (0.48–1.11)
 No 40 (40.0%) 60 (60.0%)
Primiparous 0.12
 Yes 308 (49.5%) 314 (50.5%) 0.85 (0.69–1.04)
 No 415 (45.4%) 498 (54.6%)
 Educational level 0.02
 High School diploma or equivalent or less 93 (49.0%) 97 (51.0%)
 Associate or bachelor degree 382 (44.0%) 486 (56.0%) 1.22 (0.89–1.67)
 More than bachelor degree 239 (52.1%) 220 (47.9%) 0.88 (0.63–1.24)
Health insurance type  < 0.0001
 Any private 57 (50.7%) 503 (49.3%)
 Public, no private 177 (38.8%) 279 (61.2%) 1.62 (1.29–2.03)
Household income  < 0.0001
  < $25,000 42 (34.4%) 80 (65.6%)
 $25,000-$49,999 83 (39.2%) 129 (60.8%) 0.82 (0.51–1.30)
 $50,000-$74,999 72 (40.0%) 108 (60.0%) 0.79 (0.49–1.27)
 $75,000-$149,999 209 (52.1%) 192 (47.9%) 0.48 (0.32–0.74)
 $150,000 or more 151 (55.3%) 122 (44.7%) 0.42 (0.27–0.66)
Survey language 0.41
 English 731 (47.0%) 826 (53.0%)
 Spanish 5 (35.7%) 9 (64.3%) 1.59 (0.53–4.78)

*p-value is based on Wald Chi-square test from logistic regression

aUnadjusted odds ratio (OR) > 1 reflects elements associated with increased odds of not receiving antepartum Tdap, while OR < 1 demonstrates decreased odds of non-receipt (i.e., more likely to receive antepartum Tdap vaccine)